NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Eli Lilly acquires promising PI3Kα inhibitor from Scorpion Therapeutics Eli Lilly and Company (Lilly) has announced a significant acquisition of Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program, a… byPallavi MadhirajuJanuary 15, 2025